Description
A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02026-01-01$10,994,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2026-01-01(start date) | $10,994,000 | — | A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 706842473)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 018-2025-2026-Q4-13-RD028 | National Defence | Défense nationale · Funding for Canadian Innovators and Accelerators of DIANA (FCIA-DIANA) | $169,000 | FY2026 |
| 033-2025-2026-Q4-515746 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Life Sciences Fund Contributions | $10,994,000 | FY2026 |
| 172-2025-2026-Q1-1030906 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $255,000 | FY2026 |
| 172-2023-2024-Q1-1006507 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $557,000 | FY2024 |
| 172-2022-2023-Q3-996471 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $170,819 | FY2023 |
| 172-2021-2022-Q2-974580 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $45,000 | FY2022 |
Other recipients funded under "Life Sciences Fund Contributions" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2025-2026-Q4-515888 | STEMCELL Technologies Canada Inc. | FY2026 | $2,829,286 | FY2026 |
| 033-2025-2026-Q4-515742 | Applied Pharmaceutical Innovation | FY2026 | $21,928,275 | FY2026 |
| 033-2025-2026-Q4-515743 | Northern RNA Inc. | FY2026 | $6,037,700 | FY2026 |
| 033-2025-2026-Q4-515741 | Qidni Labs Inc. | FY2026 | $12,500,000 | FY2026 |
| 033-2025-2026-Q4-515751 | Canadian Blood Services | FY2026 | $75,000,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2025-2026-Q4-515732 · retrieved 2026-11-12.